According to a letter dated April 4, 2016, the Drug Enforcement Administration is currently assessing the Food and Drug Administration’s recommendation to reschedule marijuana in accordance with the requirements of the Controlled Substances Act, as well as the Department of Health and Human Services’ recommendation to reschedule marijuana.
“DEA understands the widespread interest in the prompt resolution of these petitions and hopes to release its determination in the first half of 2016,” read the letter, signed by Sylvia M. Burwell, Secretary of DHHS; Michael Botticelli, Director of the Office of National Drug Control Policy; and Chuck Rosenberg, Acting Administrator, DEA.
The DEA’s letter is a reply to the 2015 letter from eight U.S. Senators who urged the federal government to research the potentially beneficial medicinal properties of marijuana.
“[There is] absolutely no reason marijuana should remain in Schedule I,” said Tom Angell, a marijuana policy reform activist, in a statement to The Huffington Post.